Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-848P is a **pseudogene** belonging to the U6 small nuclear RNA gene family. Pseudogenes are typically genomic DNA sequences similar to known genes but are generally non-functional; they result from gene duplication or retrotransposition events and do not produce functional RNA or protein products. The genuine U6 snRNA plays a critical role in the spliceosome, catalyzing the excision of introns from pre-mRNA during RNA splicing in the nucleus of eukaryotic cells[1][3]. However, RNU6-848P does not participate in splicing or any recognized biological process[2][4][5]. There is no indication that this particular pseudogene is associated with disease, targeted by drugs, or used as a biomarker. Like other U6-related pseudogenes, it serves primarily as a reflectance of the gene family’s evolutionary history and is not considered an actionable target in biomedical contexts[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 848, pseudogene (RNU6-848P).